Cited by 199Diabetes, Cardiovascular Risks, and LipoproteinsHealth Promotion and Cardiovascular PreventionDiabetes Management and Research

The DOI matches its Crossref record; 46 of the 49 references it cites were found in a registry or an index.

Validation of the Finnish diabetes risk score (FINDRISC) questionnaire for screening for undiagnosed type 2 diabetes, dysglycaemia and the metabolic syndrome in Greece

Makrilakis, K., Liatis, S., Grammatikou, S., Perrea, D., Stathi, C., Tsiligros, P., Katsilambros, N.·2011·Diabetes & Metabolism

DOI 10.1016/j.diabet.2010.09.006

Open this paper in CoChat — free account

Abstract

Aim The present study aimed to validate the Finnish Type 2 Diabetes Risk Score (FINDRISC) questionnaire for its ability to predict the presence of any glucose homoeostasis abnormalities and the metabolic syndrome (MetS) in the Greek population. Methods Validation was performed on a sample of individuals who had agreed to participate in a screening program for type 2 diabetes (T2D) prevention (the Greek part of the DE-PLAN study), using both FINDRISC and oral glucose tolerance tests (OGTT). Impaired fasting glucose (IFG) was defined as a fasting plasma glucose level of 6.1-6.9 mmol/L, and impaired glucose tolerance (IGT) as a 2-h plasma glucose of 7.8-11.0 mmol/L. The predictive value of the FINDRISC was cross-sectionally evaluated using the area under the receiver operating characteristic (AUROC) curve method. Results A total of 869 individuals (379 men, aged 56.2 ± 10.8 years) were screened from the general population living in the city and suburbs of Athens. OGTT revealed the presence of unknown diabetes in 94 cases (10.8%), IFG in 85 (9.8%) and IGT in 109 (12.6%). The sensitivity of a FINDRISC score greater or equal to 15 (45% of the population) to predict unknown diabetes was 81.9% and its specificity was 59.7%. The AUROC curve for detecting unknown diabetes was 0.724 (95% CI: 0.677-0.770). For any dysglycaemia, the AUROC curve was 0.716 (0.680-0.752) while, for detection of the MetS, it was 0.733 (0.699-0.767). Conclusion The FINDRISC questionnaire performed well as a sc…

Integrity signals

Registry

Crossref · 10.1016/j.diabet.2010.09.006

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 14,094
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.
(2002) · Circulation · doi:10.1161/circ.106.25.3143 · Cited by 14,092
Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873 · cited 2×
“[3] Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, IlanneParikka P, et al.”
Background
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s062 · Cited by 5,491
Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial
Chiasson, J.-L., Josse, R. G., Gomis, R., Hanefeld, M., Karasik, A., & Laakso, M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08905-5 · Cited by 2,543
The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes
Kahn, S. E. (2003) · Diabetologia · doi:10.1007/s00125-002-1009-0 · Cited by 2,166
The Diabetes Risk Score
Lindström, J., & Tuomilehto, J. O. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.725 · Cited by 1,937

Show all 49 references

Sorted by citations

Diabetes Mellitus: Screening and Diagnosis.
Pippitt, K. A., Li, M., & Gurgle, H. E. (2016) · PubMed · Cited by 153
Evaluation of Finnish Diabetes Risk Score in Screening Undiagnosed Diabetes and Prediabetes among U.S. Adults by Gender and Race: NHANES 1999-2010
Zhang, L., Zhang, Z., Zhang, Y., Hu, G., & Chen, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097865 · Cited by 130
Circulating miRNAs as Predictive Biomarkers of Type 2 Diabetes Mellitus Development in Coronary Heart Disease Patients from the CORDIOPREV Study
Jiménez-Lucena, R., Rangel-Zúñiga, O. A., Alcala-Diaz, J. F., López-Moreno, J., Roncero‐Ramos, I., Molina‐Abril, H., Yubero‐Serrano, E. M., Caballero‐Villarraso, J., Delgado‐Lista, J., Castano, J. P., et al. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.05.002 · Cited by 121
Shifting from glucose diagnosis to the new HbA1c diagnosis reduces the capability of the Finnish Diabetes Risk Score (FINDRISC) to screen for glucose abnormalities within a real-life primary healthcare preventive strategy
Costa, B., Barrio, F., Piñol, J. L., Cabré, J.-J., Mundet, X., Sagarra-Alamo, R., Salas‐Salvadó, J., & Solà-Morales, O. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-45 · Cited by 71
Evaluation of the Finnish Diabetes Risk Score to predict type 2 diabetes mellitus in a Colombian population: A longitudinal observational study
Gómez-Arbeláez, D. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i17.1337 · Cited by 64
Evaluation of the Finnish Diabetes Risk Score (FINDRISC) as a Screening Tool for the Metabolic Syndrome
Janghorbani, M., Adineh, H. A., & Amini, M. (2013) · The Review of Diabetic Studies · doi:10.1900/rds.2013.10.283 · Cited by 62
Guía de práctica clínica para la prevención, diagnóstico, tratamiento y seguimiento de la diabetes mellitus tipo 2 en la población mayor de 18 años
Montoya, P. A., Múñoz, Ó., Cardozo, D. M. G., García, O. M., Fernandez-Ávila, D. G., Casas, L. Á., Bohórquez, L. F., Toro, C. M. A., Carvajal, L., de Peña, D. R., et al. (2016) · Colombia medica · doi:10.25100/cm.v47i2.2207 · Cited by 60
Performance of the Finnish Diabetes Risk Score and a Simplified Finnish Diabetes Risk Score in a Community-Based, Cross-Sectional Programme for Screening of Undiagnosed Type 2 Diabetes Mellitus and Dysglycaemia in Madrid, Spain: The SPREDIA-2 Study
Salinero-Fort, M. Á., de Burgos‐Lunar, C., Lahoz, C., Mostaza, J. M., Abánades-Herranz, J. C., Cuesta, F. L., Cabo, E. E.-D., García-Iglesias, F., González-Alegre, T., Fernández-Puntero, B., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158489 · Cited by 65
TRAF4 functions as an intermediate of GITR-induced NF-?B activation
Esparza, E. M., & Arch, R. H. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4417-0 · Cited by 56
Evaluation of the Finnish Diabetes Risk Score (FINDRISC) for diabetes screening in occupational health care.
Vandersmissen, G., & Godderis, L. (2015) · International Journal of Occupational Medicine and Environmental Health · doi:10.13075/ijomeh.1896.00407 · Cited by 44
The performance of the Finnish Diabetes Risk Score, a modified Finnish Diabetes Risk Score and a simplified Finnish Diabetes Risk Score in community-based cross-sectional screening of undiagnosed type 2 diabetes in the Philippines
Ku, G. M., & Kegels, G. (2013) · Primary care diabetes · doi:10.1016/j.pcd.2013.07.004 · Cited by 49
Evaluation of the Finnish Diabetes Risk Score as a screening tool for undiagnosed type 2 diabetes and dysglycaemia among early middle-aged adults in a large-scale European cohort. The Feel4Diabetes-study
Mavrogianni, C., Lambrinou, C., Androutsos, O., Lindström, J., Kivelä, J., Cardon, G., Huys, N., Tsochev, Κ., Iotova, V., Chakarova, N. Y., et al. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.02.017 · Cited by 48
Self-citation
Three-stage intelligent support of clinical decision making for higher trust, validity, and explainability
Kovalchuk, S. V., Kopanitsa, G., Derevitskii, I. V., Matveev, G. A., & Savitskaya, D. A. (2022) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2022.104013 · Cited by 52
Prevalence of people at risk of developing type 2 diabetes mellitus and the involvement of community pharmacies in a national screening campaign: a pioneer action in Brazil
Correr, C. J., Coura‐Vital, W., Frade, J. C. Q. P., do Nascimento, R. C. R. M., Nascimento, L. G., Pinheiro, E. B., Ferreira, W. M., Reis, J. S., Melo, K., Pontarolo, R., et al. (2020) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-020-00593-5 · Cited by 46
The Association between Dyslipidemia, Dietary Habits and Other Lifestyle Indicators among Non-Diabetic Attendees of Primary Health Care Centers in Jeddah, Saudi Arabia
Enani, S. M., Bahijri, S., Malibary, M., Jambi, H., Eldakhakhny, B. M., Al-Ahmadi, J., Al-Raddadi, R. M., Ajabnoor, G., Boraie, A., & Tuomilehto, J. O. (2020) · Nutrients · doi:10.3390/nu12082441 · Cited by 42
Prediabetes/diabetes screening strategy at the periodontal clinic
Grigoriadis, A., Räisänen, I. T., Pärnänen, P., Tervahartiala, T. I., Sorsa, T. A., & Sakellari, D. (2020) · Clinical and Experimental Dental Research · doi:10.1002/cre2.338 · Cited by 42
A Novel Testing Model for Opportunistic Screening of Pre-Diabetes and Diabetes among U.S. Adults
Zhang, Y., Hu, G., Zhang, L., Mayo, R., & Chen, L. (2015) · PLOS ONE · doi:10.1371/journal.pone.0120382 · Cited by 41
“Moreover, FINDRISC is the most commonly evaluated diabetes risk score worldwide [17,18,19,20,21,22,23,24,25] and has been recommended as the best available risk assessment tool for use in the clinical practice by a systematic review [11].”
BackgroundMethod
Prevalence and predictors of diabetes and cardiometabolic risk among construction workers in Ireland: The Construction Workers Health Trust screening study
Thabit, H., Burns, N., Shah, S., Brema, I., Crowley, V., Finnegan, F. R., Daly, B., & Nolan, J. (2013) · Diabetes & vascular disease research · doi:10.1177/1479164113479808 · Cited by 39
Validation of the Finnish Diabetes Risk Score (FINDRISC) questionnaire for undiagnosed type 2 diabetes screening in the Slovenian working population.
Štiglic, G., Fijačko, N., Stožer, A., Sheikh, A., & Pajnkihar, M. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.08.010 · Cited by 48
Validity of the Finnish Diabetes Risk Score for Detecting Undiagnosed Type 2 Diabetes among General Medical Outpatients in Botswana
Omech, B., Mwita, J. C., Tshikuka, J., Tsima, B. M., Nkomazna, O., & Amone‐P’Olak, K. (2016) · Journal of Diabetes Research · doi:10.1155/2016/4968350 · Cited by 37
Challenges associated with missing data in electronic health records: A case study of a risk prediction model for diabetes using data from Slovenian primary care
Štiglic, G., Kocbek, P., Fijačko, N., Sheikh, A., & Pajnkihar, M. (2017) · Health Informatics Journal · doi:10.1177/1460458217733288 · Cited by 37
Prevalence of undiagnosed abnormal glucose tolerance in adult patients cared for by general practitioners in Hungary. Results of a risk-stratified screening based on FINDRISC questionnaire
Winkler, G., Hídvégi, T., Vándorfi, G., Balogh, S., & Jermendy, G. (2013) · Medical Science Monitor · doi:10.12659/msm.883747 · Cited by 36
“2% of the subjects had impaired carbohydrate metabolism [14].”
BackgroundMethod
Prevalence and risk factors for diabetic retinopathy in a high-risk Chinese population
Wang, J., Zhang, R., Chen, R., Sun, J. M., Yang, R., Ke, X.-Y., Chen, H., & Cai, D.-H. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-633 · Cited by 34
Systematic Review and Meta-Analysis of Response Rates and Diagnostic Yield of Screening for Type 2 Diabetes and Those at High Risk of Diabetes
Khunti, K., Mani, H., Achana, F. A., Cooper, N. J., Gray, L. J., & Davies, M. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135702 · Cited by 39
Screening for type 2 diabetes mellitus in overweight and obese subjects made easy by the FINDRISC score
Meijnikman, A. S., Block, C. E. M. D., Verrijken, A., Mertens, I. L., Corthouts, B., & Gaal, L. F. V. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.05.004 · Cited by 35
Performance of the Finnish Diabetes Risk Score (FINDRISC) and Modified Asian FINDRISC (ModAsian FINDRISC) for screening of undiagnosed type 2 diabetes mellitus and dysglycaemia in primary care
Lim, H. M., Chia, Y. C., & Koay, Z. L. (2020) · Primary care diabetes · doi:10.1016/j.pcd.2020.02.008 · Cited by 38
Predicting type 2 diabetes mellitus: a comparison between the FINDRISC score and the metabolic syndrome
Meijnikman, A. S., Block, C. E. M. D., Verrijken, A., Mertens, I. L., & Gaal, L. F. V. (2018) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-018-0310-0 · Cited by 33
A Deep Learning Model for Estimation of Patients with Undiagnosed Diabetes
Ryu, K. S., Lee, S., Batbaatar, E., Lee, J. W., Choi, K. S., & Cha, H. S. (2020) · Applied Sciences · doi:10.3390/app10010421 · Cited by 28
Finnish Diabetes Risk Score Is Associated with Impaired Insulin Secretion and Insulin Sensitivity, Drug-Treated Hypertension and Cardiovascular Disease: A Follow-Up Study of the METSIM Cohort
Fizelova, M., Jauhiainen, R., Stančáková, A., Kuusisto, J., & Laakso, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166584 · Cited by 31
Diagnostic accuracy of the Finnish Diabetes Risk Score for the prediction of undiagnosed type 2 diabetes, prediabetes, and metabolic syndrome in the Lebanese University
Abdallah, M., Sharbaji, S., Sharbaji, M., Daher, Z., Faour, T., Mansour, Z., & Hneino, M. (2020) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-020-00590-8 · Cited by 34
The effectiveness of a community-based, type 2 diabetes prevention programme on health-related quality of life. The DE-PLAN study
Karamanakos, G., Costa, B., Gilis‐Januszewska, A., Veličkienė, D., Barrio, F., Cos, X., Mestre, S., Piwońska‐Solska, B., Hubalewska–Dydejczyk, A., Tuomilehto, J. O., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0221467 · Cited by 30
Self-citation
The Finnish Diabetes Risk Score (FINDRISC), incident diabetes and low-grade inflammation
Pesaro, A. E. P., Bittencourt, M. S., Franken, M., Carvalho, J. A. M., Bernardes, D., Tuomilehto, J. O., & Santos, R. D. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108558 · Cited by 33
Metabolic Age, an Index Based on Basal Metabolic Rate, Can Predict Individuals That are High Risk of Developing Metabolic Syndrome
Vásquez-Alvarez, S., Bustamante-Villagomez, S. K., Vazquez-Marroquin, G., Porchia, L. M., Pérez-Fuentes, R., Torres‐Rasgado, E., Herrera-Fomperosa, O., Montes-Arana, I., & González-Mejía, M. E. (2021) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-021-00441-1 · Cited by 31
Finnish Diabetes Risk Score to predict type 2 diabetes in the Isfahan diabetes prevention study
Janghorbani, M., Adineh, H., & Amini, M. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.10.018 · Cited by 30
Evaluation of the modified FINDRISC to identify individuals at high risk for diabetes among middle‐aged white and black ARIC study participants
Kulkarni, M., Foraker, R. E., McNeill, A. M., Girman, C. J., Golden, S. H., Rosamond, W. D., Duncan, B. B., Schmidt, M. I., & Tuomilehto, J. O. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12949 · Cited by 28
Evaluating FINDRISC as a screening tool for type 2 diabetes among overweight adults in the PREVIEW:NZ cohort
Silvestre, M. P., Jiang, Y., Volkova, K., Chisholm, H., Lee, W., & Poppitt, S. D. (2017) · Primary care diabetes · doi:10.1016/j.pcd.2017.07.003 · Cited by 30
Development of a screening tool using electronic health records for undiagnosed Type 2 diabetes mellitus and impaired fasting glucose detection in the Slovenian population
Štiglic, G., Kocbek, P., Cilar, L., Fijačko, N., Stožer, A., Zaletel, J., Sheikh, A., & Bržan, P. P. (2018) · Diabetic Medicine · doi:10.1111/dme.13605 · Cited by 28
Comparison of health-related quality of Life (HRQOL) among patients with pre-diabetes, diabetes and normal glucose tolerance, using the 15D-HRQOL questionnaire in Greece: the DEPLAN study
Makrilakis, K., Liatis, S., Tsiakou, A., Stathi, C., Papachristoforou, E., Perrea, D., Katsilambros, N., Kontodimopoulos, N., & Niakas, D. (2018) · BMC Endocrine Disorders · doi:10.1186/s12902-018-0261-3 · Cited by 27
Self-citation
Prevalence and screening for risk factors of type 2 diabetes in Rize, Nourtheast Turkey: findings from a population-based study
Çevik, A. B., Karaaslan, M. M., Kocan, S. H., Pekmezci, H., Şahin, S. B., Kırbaş, A., & Ayaz, T. (2015) · Primary care diabetes · doi:10.1016/j.pcd.2015.06.002 · Cited by 27
Prevalence of diabetes and pre-diabetes in Greece. Results of the First National Survey of Morbidity and Risk Factors (EMENO) study
Makrilakis, K., Kalpourtzi, N., Ioannidis, I., Iraklianou, S. A., Raptis, A. E., Sotiropoulos, A., Gavana, M., Vantarakis, A., Καντζάνου, Μ., Hadjichristodoulou, C. S., et al. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108646 · Cited by 29
Self-citation
Validating prediction scales of type 2 diabetes mellitus in Spain: the SPREDIA-2 population-based prospective cohort study protocol
Salinero-Fort, M. Á., de Burgos‐Lunar, C., Prieto, J. M. M., Lahoz, C., Abánades-Herranz, J. C., Gómez‐Campelo, P., Cuesta, F. L., de Cabo, E. E., García-Iglesias, F., González-Alegre, T., et al. (2015) · BMJ Open · doi:10.1136/bmjopen-2014-007195 · Cited by 29
Exceso de peso y riesgo cardiometabólico en docentes de una universidad de Lima: oportunidad para construir entornos saludables
Morales, J., Matta, H., Fuentes-Rivera, J., Pérez, R., Suárez, C., Alvines, D., & Carcausto, W. (2017) · Educación Médica · doi:10.1016/j.edumed.2017.08.003 · Cited by 24
Clinical practice guideline for the prevention, early detection, diagnosis, management and follow up of type 2 diabetes mellitus in adults.
Pablo Aschner, M., Múñoz, Ó., Cardozo, D. M. G., García, O. M., Fernández-Ávila, D. G., Casas, L. Á., Bohórquez, L. F., Toro, C. M. A., Carvajal, L., de Peña, D. R., et al. (2016) · Europe PMC (PubMed Central) · Cited by 24
Dysglycemia risk score in Saudi Arabia: A tool to identify people at high future risk of developing type 2 diabetes
Bahijri, S., Al-Raddadi, R. M., Ajabnoor, G., Jambi, H., Al-Ahmadi, J., Borai, A., Barengo, N. C., & Tuomilehto, J. O. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13213 · Cited by 27
Heart rate variability based on risk stratification for type 2 diabetes mellitus
Silva-e-Oliveira, J., Amélio, P. M., Abranches, I. L. L., Damasceno, D. D., & Furtado, F. (2017) · Einstein (São Paulo) · doi:10.1590/s1679-45082017ao3888 · Cited by 24
Determining type 2 diabetes risk factors for the adults: A community based study from Turkey.
Cosansu, G., Çelik, S., Özcan, Ş., Olgun, N., Yıldırım, N., & Demir, H. G. (2018) · Primary Care Diabetes · doi:10.1016/j.pcd.2018.05.001 · Cited by 27
Mobile Applications for Type 2 Diabetes Risk Estimation: a Systematic Review
Fijačko, N., Povalej, P., & Štiglic, G. (2015) · Journal of Medical Systems · doi:10.1007/s10916-015-0319-y · Cited by 24
A community-based primary prevention programme for type 2 diabetes mellitus integrating identification and lifestyle intervention for prevention: a cluster randomised controlled trial
Davies, M. J., Gray, L. J., Ahrabian, D., Carey, M., Farooqi, A., Gray, A. M., Goldby, S., Hill, S., Jones, K. L., Leal, J., et al. (2017) · Programme Grants for Applied Research · doi:10.3310/pgfar05020 · Cited by 26
Aile hekimliğine başvuran bireylerde tip 2 diyabet risk düzeyinin belirlenmesi
Kulak, E., Berber, B., Temel, H., Kutluay, S. N., Yıldırım, M., Dedeoğlu, F. N., Çifçili, S., & Save, D. (2019) · Turkish Journal of Family Practice · doi:10.15511/tahd.19.00120 · Cited by 23
Changes in dietary habits and their association with metabolic markers after a non-intensive, community-based lifestyle intervention to prevent type 2 diabetes, in Greece. The DEPLAN study
Kontogianni, M. D., Liatis, S., Grammatikou, S., Perrea, D. N., Katsilambros, N. L., & Makrilakis, K. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.09.010 · Cited by 23
Self-citation
Evaluation of the Japanese Metabolic Syndrome Risk Score (JAMRISC): a newly developed questionnaire used as a screening tool for diagnosing metabolic syndrome and insulin resistance in Japan
Tan, C., Sasagawa, Y., Kamo, K., Kukitsu, T., Noda, S., Ishikawa, K., Yamauchi, N., Saikawa, T., Noro, T., Nakamura, H., et al. (2016) · Environmental Health and Preventive Medicine · doi:10.1007/s12199-016-0568-5 · Cited by 22
Prediction of 4-year incident diabetes in older Chinese: Recalibration of the Framingham diabetes score on Guangzhou Biobank Cohort Study
Xu, L., Jiang, C. Q., Schooling, C. M., Zhang, W. S., Cheng, K. K., & Lam, T. (2014) · Preventive Medicine · doi:10.1016/j.ypmed.2014.09.004 · Cited by 21
Frequency of diabetes, impaired fasting glucose, and glucose intolerance in high-risk groups identified by a FINDRISC survey in Puebla City, Mexico
Garcia-Alcala, H., Soto Vega, E., Genestier Tamborero, C. N., Salinas Palma, J. L., & Hirales Tamez, O. (2012) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s35545 · Cited by 21
“The Finnish type 2 Diabetes Risk Assessment (FINDRISC) survey developed in 2001 has been widely used and validated in different countries and epidemiologic studies as an instrument to identify patients at risk of developing diabetes and prediabetic states.(7) The aim of this study was to evaluate the prevalence of dia…”
Method
Skin autofluorescence improves the Finnish Diabetes Risk Score in the detection of diabetes in a large population-based cohort: The LifeLines Cohort Study.
Fokkens, B., van Waateringe, R. V., Mulder, D., Wolffenbuttel, B., & Smit, A. (2017) · Diabetes & Metabolism · doi:10.1016/j.diabet.2017.09.002 · Cited by 21
Parenting Practices as a Mediator in the Association Between Family Socio-Economic Status and Screen-Time in Primary Schoolchildren: A Feel4Diabetes Study
Lepeleere, S. D., Bourdeaudhuij, I. D., Stappen, V. V., Huys, N., Latomme, J., Androutsos, O., Μanios, Y., Cardon, G., & Verloigne, M. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15112553 · Cited by 20
Signs of subclinical atherosclerosis in asymptomatic patients at increased risk of type 2 diabetes mellitus
Kiss, L. Z., Bagyura, Z., Vadas, R., Polgár, L., Lux, Á., Édes, E., Szenczi, O., Soós, P., Szelid, Z., Becker, D. J., et al. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.05.007 · Cited by 20
Large scale application of the Finnish diabetes risk score in Latin American and Caribbean populations: a descriptive study
Nieto-Martínez, R. E., Barengo, N. C., Restrepo, M. L., Grinspan, A., Assefi, A. R., & Mechanick, J. I. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1188784 · Cited by 26
Validation of the Finnish diabetes risk score (FINDRISC) for the Caucasian population of Siberia
Mustafina, S. V., Rymar, O. D., Sazonova, O. V., Щербакова, Л. В., & Voevoda, M. I. (2016) · Diabetes Mellitus · doi:10.14341/dm200418-10 · Cited by 22
Evaluation of EZSCAN as a screening tool for impaired glucose metabolism
Chen, L., Chen, X.-L., Ding, R., Shi, Q.-T., & Hu, D. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.03.001 · Cited by 20
Baseline osteocalcin levels and incident diabetes in a 3-year prospective study of high-risk individuals
Liatis, S., Sfikakis, P. P., Tsiakou, A. G., Stathi, C., Terpos, E., Katsilambros, N. L., & Makrilakis, K. (2014) · Diabetes & Metabolism · doi:10.1016/j.diabet.2014.01.001 · Cited by 18
Self-citation
Efficacy of a church-based lifestyle intervention programme to control high normal blood pressure and/or high normal blood glucose in church members: a randomized controlled trial in Pretoria, South Africa
Pengpid, S., Peltzer, K., & Skaal, L. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-568 · Cited by 18
Kernel machine learning methods to handle missing responses with complex predictors. Application in modelling five-year glucose changes using distributional representations
Matabuena, M., Félix, P., Meijide-Garcia, C., & Gudé, F. (2022) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2022.106905 · Cited by 17
Detecting persons at risk for diabetes mellitus type 2 using FINDRISC: results from a community pharmacy-based study
Milovanovic, S., Silenzi, A., Kheiraoui, F., Ventriglia, G., Boccia, S., & Poscia, A. (2018) · European Journal of Public Health · doi:10.1093/eurpub/cky009 · Cited by 19
Screening for people with abnormal glucose metabolism in the European DE-PLAN project
Cos, X., Barengo, N. C., Costa, B., Mundet, X., Lindström, J., & Tuomilehto, J. O. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.04.016 · Cited by 19
Predictors of diabetes risk in urban and rural areas in Colombia
Molina, R. T., García, A. L. R., Acosta, T., Flórez‐García, V., Gutierrez, V. R., Lozano, K. C. F., & Barengo, N. C. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e08653 · Cited by 1
Diabetes risk assessment among squatter settlements in Pakistan: A cross-sectional study.
Ishaque, A., Shahzad, F., Muhammad, F. H., Usman, Y., & Ishaque, Z. (2016) · Europe PMC (PubMed Central) · Cited by 16
The effect of a cluster-randomized controlled trial on lifestyle behaviors among families at risk for developing type 2 diabetes across Europe: the Feel4Diabetes-study
Stappen, V. V., Cardon, G., Craemer, M. D., Mavrogianni, C., Usheva, N., Kivelä, J., Wikström, K., Miguel‐Etayo, P. D., González‐Gil, E. M., Radó, A. S., et al. (2021) · International Journal of Behavioral Nutrition and Physical Activity · doi:10.1186/s12966-021-01153-4 · Cited by 16
Health-related quality of life (HRQoL) in a population at risk of type 2 diabetes: a cross-sectional study in two Latin American cities
Arrieta, L. A. A., Acosta, T., Molina, R. T., Acosta, S. M. R., Lozano, K. C. F., Aschner, P. J., Gabriel, R., de la Rosa, S., Castillo, J. P. N., & Barengo, N. C. (2021) · Health and Quality of Life Outcomes · doi:10.1186/s12955-021-01894-7 · Cited by 15
The Finnish Diabetes Risk Score (FINDRISC) and other non-invasive scores for screening of hepatic steatosis and associated cardiometabolic risk
Musso, G. (2011) · Annals medicus · doi:10.3109/07853890.2011.579152 · Cited by 11
Detección de personas en riesgo de padecer diabetes en farmacias comunitarias de Pontevedra (DEDIPO)
Fornos-Pérez, J. A., Rodríguez, N. F. A., Andrés-Iglesias, J. C., Luna-Cano, R., Soidán, F. J. G., Lorenzo-Veiga, B., Mera-Gallego, R., & García-Riestra, R. (2016) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2016.06.002 · Cited by 18
FINDRISC Modified for Latin America as a Screening Tool for Persons with Impaired Glucose Metabolism in Ciudad Bolívar, Venezuela
Muñoz-González, M. C., Lima-Martínez, M. M., Nava, A., Trerotola, G., Paoli, M., Cabrera-Rego, J. O., Gonzalez, B., Arciniegas, A., & Paez, J. (2019) · Medical Principles and Practice · doi:10.1159/000499468 · Cited by 12
Prevalence of increased risk of type 2 diabetes in general practice: a cross-sectional study in Norway
Riise, H. K. R., Graue, M., Igland, J., Birkeland, K. I., & Kolltveit, B. H. (2023) · BMC Family Practice · doi:10.1186/s12875-023-02100-x · Cited by 15
Detection of people at risk of diabetes in community pharmacies of Pontevedra (Spain) (DEDIPO)
Fornos-Pérez, J. A., Rodríguez, N. F. A., Andrés-Iglesias, J. C., Luna-Cano, R., Soidán, F. J. G., Lorenzo-Veiga, B., Mera-Gallego, R., & García-Riestra, R. (2016) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2016.10.002 · Cited by 14
The Association Between Dietary Habits and Other Lifestyle Indicators and Dysglycemia in Saudi Adults Free of Previous Diagnosis of Diabetes
Jambi, H., Enani, S. M., Malibary, M., Bahijri, S., Eldakhakhny, B. M., Al-Ahmadi, J., Al-Raddadi, R. M., Ajabnoor, G., Boraie, A., & Tuomilehto, J. O. (2020) · Nutrition and Metabolic Insights · doi:10.1177/1178638820965258 · Cited by 13
Frequency of family meals and food consumption in families at high risk of type 2 diabetes: the Feel4Diabetes-study
Mahmood, L., González‐Gil, E. M., Schwarz, P. E. H., Herrmann, S., Karaglani, E., Cardon, G., Vylder, F. D., Willems, R. P., Makrilakis, K., Liatis, S., et al. (2022) · European Journal of Pediatrics · doi:10.1007/s00431-022-04445-4 · Cited by 13
Self-citation
Performance of a Finnish Diabetes Risk Score in detecting undiagnosed diabetes among Kenyans aged 18–69 years
Mugume, I. B., Wafula, S. T., Kadengye, D. T., & van Olmen, J. (2023) · PLoS ONE · doi:10.1371/journal.pone.0276858 · Cited by 13
Early Lifestyle Interventions in People with Impaired Glucose Tolerance in Northern Colombia: The DEMOJUAN Project
Barengo, N. C., Acosta, T., Arrieta, A., Ricaurte, C., Šmits, D., Florez, K., & Tuomilehto, J. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16081403 · Cited by 13
Characteristics of men classified at high-risk for type 2 diabetes mellitus using the AUSDRISK screening tool
Aguiar, E. J., Morgan, P. J., Collins, C. E., Plotnikoff, R. C., & Callister, R. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.01.017 · Cited by 13
A Mobile App for Identifying Individuals With Undiagnosed Diabetes and Prediabetes and for Promoting Behavior Change: 2-Year Prospective Study
Leung, A. Y. M., Xu, X., Chau, P. H., Yu, E. Y. T., Cheung, M. K. T., Wong, C. K. H., Fong, D., Wong, J. Y. H., & Lam, C. L. K. (2018) · JMIR mhealth and uhealth · doi:10.2196/10662 · Cited by 13
Metabolic Syndrome and Diabetes Risk Among Young Adult Students in the Health Sciences from Kathmandu, Nepal
Sapkota, M., Timilsina, A., Shakya, M., Thapa, T. B., Shrestha, S., Pokhrel, S., Devkota, N., & Pardhe, B. D. (2020) · Drug Healthcare and Patient Safety · doi:10.2147/dhps.s258331 · Cited by 12
The effect of a non-intensive community-based lifestyle intervention on the prevalence of Metabolic Syndrome. The DEPLAN study in Greece
Makrilakis, K., Grammatikou, S., Liatis, S., Kontogianni, M. D., Perrea, D. N., Dimosthenopoulos, C., Poulia, K., & Katsilambros, N. L. (2012) · HORMONES · doi:10.14310/horm.2002.1360 · Cited by 12
Self-citation
Diyabet Risk Farkındalığı: Bir Metropol Örneği
Erdoğan, G., & Coşansu, G. (2021) · STED / Sürekli Tıp Eğitimi Dergisi · doi:10.17942/sted.876596 · Cited by 12
The European perspective of diabetes prevention: The need for individualization of diabetes prevention
Müller, G., Weser, G., & Schwarz, P. E. H. (2013) · Journal of Endocrinological Investigation · doi:10.1007/bf03347104 · Cited by 12
Prediction of a 10-year risk of type 2 diabetes mellitus in the Turkish population
Sezer, Ö., Lafçi, N. Ö., Korkmaz, S., & Dağdeviren, H. N. (2021) · Medicine · doi:10.1097/md.0000000000027721 · Cited by 13
Association Between Anthropometric Indices and Nonanthropometric Components of Metabolic Syndrome in Saudi Adults
Al-Ahmadi, J., Enani, S. M., Bahijri, S., Al-Raddadi, R. M., Jambi, H., Eldakhakhny, B. M., Borai, A., Ajabnoor, G., & Tuomilehto, J. O. (2022) · Journal of the Endocrine Society · doi:10.1210/jendso/bvac055 · Cited by 14
THE ASSESMENT OF RELATION BETWEEN WAIST/HEIGHT RATIO AND TYPE 2 DIABETES RISK AMONG NURSING STUDENTS
Gezer, C. (2017) · Journal of Food and Health Science · doi:10.3153/jfhs17017 · Cited by 11
Bittersweet: How prices of sugar-rich foods contribute to the diet-related disease epidemic in Mexico
Gračner, T. (2021) · Journal of Health Economics · doi:10.1016/j.jhealeco.2021.102506 · Cited by 12
Translation, cross-cultural adaptation and validation of the Finnish Diabetes Risk Score (FINDRISC) for use in Brazilian Portuguese: questionnaire validity study
Conceição, A. L. O., Côrrea, N. D. C., Ferreira, P. R., Rêgo, A. S., Silva, F. B., de Carvalho, S. T. R. F., Dias, R. D. S., Paz, B. K. B., Rocha, V. C. D. C., & Dibai, D. B. (2020) · Sao Paulo Medical Journal · doi:10.1590/1516-3180.2019.0524.05032020 · Cited by 13
Assessment of risk and prevention of type 2 diabetes in primary health care
Saaristo, T. (2011) · Cited by 10
Finnish diabetes risk score (findrisc) for type 2 diabetes screening compared with the oral glucose tolerance test: A systematic review and meta-analysis of diagnostic test accuracy
Acosta-Reyes, J. L., Garrido, D. P. R., Acosta, T., Aschner, P. J., Fraga, C. A., Vázquez‐Fernández, A., Tuomilehto, J. O., & Gabriel, R. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112480 · Cited by 15
Use of clinical scores to detect dysglycaemia in overweight or obese women
Cosson, E., Chiheb, S., Hamo-Tchatchouang, E., Nguyen, T. M., Aout, M., Banu, I., Cussac-Pillegand, C., Vicaut, É., & Valensi, P. E. (2012) · Diabetes & Metabolism · doi:10.1016/j.diabet.2011.11.007 · Cited by 10
Assessment of the FINDRISC tool in predicting the risk of developing type 2 diabetes mellitus in a young adult Nigerian population
Nnamudi, A. C., Orhue, N. E. J., & Ijeh, I. I. (2020) · Bulletin of the National Research Centre/Bulletin of the National Research Center · doi:10.1186/s42269-020-00440-7 · Cited by 10
Cross‐sectional and longitudinal associations between family meals frequency and children's overweight/obesity in families at high risk of type 2 diabetes: The Feel4Diabetes ‐ study
Mahmood, L., González‐Gil, E. M., Makrilakis, K., Liatis, S., Schwarz, P. E. H., Herrmann, S., Willems, R. P., Cardon, G., Latomme, J., Rurik, I., et al. (2023) · Pediatric Obesity · doi:10.1111/ijpo.13000 · Cited by 10
Self-citation
Screening for Type 2 Diabetes in Adults: An Updated Systematic Review
Sherifali, D. (2013) · The Open Diabetes Journal · doi:10.2174/1876524601306010001 · Cited by 9
Effect of integrating a video intervention on parenting practices and related parental self-efficacy regarding health behaviours within the Feel4Diabetes-study in Belgian primary schoolchildren from vulnerable families: A cluster randomized trial
Van Stappen, V., De Lepeleere, S., Huys, N., Latomme, J., Verloigne, M., Cardon, G., Androutsos, O., Manios, Y., De Bourdeaudhuij, I., & De Craemer, M. (2019) · PLOS ONE · doi:10.1371/journal.pone.0226131 · Cited by 9
Relationship between the Finnish Diabetes Risk Score (FINDRISC), vitamin D levels, and insulin resistance in obese subjects
Lima-Martínez, M. M., Arrau, C., Jerez, S., Paoli, M., Gonzalez-Rivas, J. P., Nieto-Martínez, R. E., & Iacobellis, G. (2016) · Primary care diabetes · doi:10.1016/j.pcd.2016.11.001 · Cited by 9
EZSCAN as a Screening Tool for Prediabetes and Diabetes in a Large Mexican Population
Sanchez Hernandez, O. E. (2015) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000505 · Cited by 8
Development and Validation of Two Self-Reported Tools for Insulin Resistance and Hypertension Risk Assessment in A European Cohort: The Feel4Diabetes-Study
Kanellakis, S., Mavrogianni, C., Karatzi, K., Lindstrom, J., Cardon, G., Iotova, V., Wikström, K., Shadid, S., Moreno, L., Tsochev, K., et al. (2020) · Nutrients · doi:10.3390/nu12040960 · Cited by 6
Self-citation
Prediabetes, undiagnosed diabetes and diabetes risk in Italy in 2017–2018: results from the first National screening campaign in community pharmacies
Brunetti, P., Baldessin, L., & Pagliacci, S. (2021) · Journal of Public Health · doi:10.1093/pubmed/fdab046 · Cited by 11
Comparison of the Finnish Diabetes Risk Score Model With the Metabolic Syndrome in a Shanghai Population
Jin, S., Chen, Q., Han, X., Liu, Y., Cai, M., Zheng, Y., & Lü, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.725314 · Cited by 9

Authors: Makrilakis, K., Liatis, S., Grammatikou, S., Perrea, D., Stathi, C., Tsiligros, P., & Katsilambros, N.
Affiliations: Laiko General Hospital of Athens (GR)
National and Kapodistrian University of Athens (GR)
Corresponding author: Makrilakis, K.
ORCID: Makrilakis, K.
Liatis, S.
Tsiligros, P.
Katsilambros, N.
Venue: Diabetes & Metabolism
Publisher: Elsevier BV
Published: 2011-04
Volume: 37
Issue: 2
Pages: 144-151
ISSN: 1262-3636 (ISSN-L)
DOI: 10.1016/j.diabet.2010.09.006
OpenAlex: W2061002349
Cited by: 199
References: 49
Citations by year: 2026: 8 · 2025: 15 · 2024: 8 · 2023: 12 · 2022: 20 · 2021: 17 · 2020: 25 · 2019: 9 · 2018: 13 · 2017: 10 · 2016: 18 · 2015: 14 · 2014: 10 · 2013: 11 · 2012: 5
FWCI: 4.60
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Diabetes & Metabolism (publishedVersion)
PubMed (publishedVersion)
Funders: Bristol-Myers Squibb
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords: FINDRISC questionnaire, type 2 diabetes prediction, undiagnosed type 2 diabetes, dysglycemia, impaired fasting glucose, impaired glucose tolerance, metabolic syndrome, diabetes screening, Greek population, questionnaire validation, oral glucose tolerance test, Athens, Greece, cross-cultural adaptation, sensitivity and specificity
MeSH terms: Adult, Aged, Blood Glucose, Cross-Sectional Studies, Diabetes Mellitus, Type 2, Fasting, Female, Finland, Glucose Tolerance Test, Greece, Humans, Male, Mass Screening, Middle Aged, Surveys and Questionnaires, Risk Factors, ROC Curve, Metabolic Syndrome, Glucose Metabolism Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Validation of the Finnish diabetes risk score (FINDRISC) questionnaire for screening for undiagnosed type 2 diabetes, dysglycaemia and the metabolic syndrome in Greece

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks